Mou Peng

608 total citations
27 papers, 427 citations indexed

About

Mou Peng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Mou Peng has authored 27 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Mou Peng's work include Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Mou Peng is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Mou Peng collaborates with scholars based in China, United States and Hong Kong. Mou Peng's co-authors include Zijun Wang, Yinhuai Wang, Lu Yi, Xingxing Zang, Deyou Zheng, Wei Yao, Phillip M. Galbo, Christopher Chang, Qianjin Lu and Hao Wang and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Mou Peng

26 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mou Peng China 12 174 144 119 85 72 27 427
Lukas Pawig Netherlands 6 159 0.9× 232 1.6× 194 1.6× 55 0.6× 37 0.5× 6 485
Sho Ohta Japan 12 307 1.8× 143 1.0× 55 0.5× 73 0.9× 39 0.5× 31 531
Susan M. Kitchen-Goosen United States 12 230 1.3× 105 0.7× 125 1.1× 84 1.0× 153 2.1× 18 466
Xingran Jiang China 10 257 1.5× 113 0.8× 102 0.9× 201 2.4× 41 0.6× 24 435
Mirella Georgouli United Kingdom 6 212 1.2× 131 0.9× 149 1.3× 101 1.2× 31 0.4× 12 408
Roxane M. Pommier France 11 224 1.3× 73 0.5× 149 1.3× 107 1.3× 47 0.7× 19 443
Hyoungseok Ju South Korea 12 205 1.2× 60 0.4× 101 0.8× 78 0.9× 47 0.7× 15 443
Michal Vočka Czechia 11 144 0.8× 57 0.4× 141 1.2× 98 1.2× 43 0.6× 56 349
Shunlin Jiang United States 10 349 2.0× 59 0.4× 104 0.9× 137 1.6× 41 0.6× 14 499

Countries citing papers authored by Mou Peng

Since Specialization
Citations

This map shows the geographic impact of Mou Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mou Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mou Peng more than expected).

Fields of papers citing papers by Mou Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mou Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mou Peng. The network helps show where Mou Peng may publish in the future.

Co-authorship network of co-authors of Mou Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Mou Peng. A scholar is included among the top collaborators of Mou Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mou Peng. Mou Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Mou, et al.. (2024). A novel compound heterozygous variant of ECEL1 induced joint dysfunction and cartilage degradation: a case report and literature review. Frontiers in Neurology. 15. 1343025–1343025. 1 indexed citations
2.
Peng, Mou, Yue Peng, Hong Li, et al.. (2024). A nomogram prediction of coronary artery dilation in Kawasaki diseases based on mtDNA copy number. Frontiers in Immunology. 15. 1448558–1448558.
3.
4.
Galbo, Phillip M., Anne Tranberg Madsen, Yang Liu, et al.. (2023). Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma. Clinical Cancer Research. 30(4). 865–876. 40 indexed citations
5.
Peng, Mou, Sichen Duan, Guoyan Lu, et al.. (2023). A novel homozygous variant of TMEM260 induced cardiac malformation and neurodevelopmental abnormality: case report and literature review. Frontiers in Medicine. 10. 1157042–1157042. 4 indexed citations
6.
Peng, Yue, Yue Zhang, Lei Liu, et al.. (2022). Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload. Theranostics. 12(16). 7009–7031. 33 indexed citations
7.
Cheng, Xu, Lizhi Zhou, Wentao Liu, et al.. (2022). Construction and Verification of Risk Predicting Models to Evaluate the Possibility of Venous Thromboembolism After Robot-Assisted Radical Prostatectomy. Annals of Surgical Oncology. 29(8). 5297–5306. 5 indexed citations
8.
Ren, Xiaoxin, Mou Peng, Xing Peng, et al.. (2022). Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity. Journal of Clinical Investigation. 132(22). 39 indexed citations
9.
Yao, Wei, Xiaoxin Ren, Phillip M. Galbo, et al.. (2021). KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. Science Immunology. 6(61). 65 indexed citations
10.
Wang, Zijun & Mou Peng. (2021). A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells. Scientific Reports. 11(1). 9164–9164. 26 indexed citations
11.
Peng, Mou, Cheng Xu, Wei Xiong, Lu Yi, & Yinhuai Wang. (2021). Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer. Frontiers in Oncology. 11. 684242–684242. 8 indexed citations
12.
Xu, Peng, Yijian Li, Mou Peng, et al.. (2021). Comparison of bipolar plasmakinetic resection of prostate versus photoselective vaporization of prostate by a three year retrospective observational study. Scientific Reports. 11(1). 10142–10142. 3 indexed citations
13.
Xu, Cheng, Mao Ding, Mou Peng, et al.. (2021). The Changing Trend in Clinical Characteristics and Outcomes of Male Patients With Urethral Stricture Over the Past 10 Years in China. Frontiers in Public Health. 9. 794451–794451. 1 indexed citations
14.
Wang, Zijun, Yijian Li, Yanjun Zhong, Yinhuai Wang, & Mou Peng. (2020). <p>Comprehensive Analysis of Aberrantly Expressed Competitive Endogenous RNA Network and Identification of Prognostic Biomarkers in Pheochromocytoma and Paraganglioma</p>. OncoTargets and Therapy. Volume 13. 11377–11395. 10 indexed citations
15.
Friedman, Debra L., Kara M. Kelly, Qinglin Pei, et al.. (2020). LAG-3 is expressed on a majority of tumor infiltrating lymphocytes in pediatric Hodgkin lymphoma. Leukemia & lymphoma. 62(3). 606–613. 13 indexed citations
16.
Meng, Zhe, Liang Zhou, Zhe Dai, et al.. (2020). The Quality of Clinical Practice Guidelines and Consensuses on the Management of Primary Aldosteronism: A Critical Appraisal. Frontiers in Medicine. 7. 136–136. 2 indexed citations
17.
Wang, Zijun, Christopher Chang, Mou Peng, & Qianjin Lu. (2017). Translating epigenetics into clinic: focus on lupus. Clinical Epigenetics. 9(1). 78–78. 35 indexed citations
18.
19.
Peng, Mou, Zijun Wang, Zhonghua Yang, et al.. (2015). Overexpression of short TRPM8 variant α promotes cell migration and invasion, and decreases starvation-induced apoptosis in prostate cancer LNCaP cells. Oncology Letters. 10(3). 1378–1384. 30 indexed citations
20.
Zhong, Yanjun, Jie Cao, Runmei Zou, & Mou Peng. (2014). Genetic polymorphisms in alcohol dehydrogenase, aldehyde dehydrogenase and alcoholic chronic pancreatitis susceptibility: A meta-analysis. Gastroenterología y Hepatología. 38(7). 417–25. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lukas Pawig Breakdown of academic impact, for papers by Sho Ohta Breakdown of academic impact, for papers by Susan M. Kitchen-Goosen Breakdown of academic impact, for papers by Xingran Jiang Breakdown of academic impact, for papers by Mirella Georgouli Breakdown of academic impact, for papers by Roxane M. Pommier Breakdown of academic impact, for papers by Hyoungseok Ju Breakdown of academic impact, for papers by Michal Vočka Breakdown of academic impact, for papers by Shunlin Jiang
Rankless by CCL
2026